Imunon Correlations

IMNN Stock  USD 0.83  0.02  2.47%   
The current 90-days correlation between Imunon Inc and Neoleukin Therapeutics is 0.03 (i.e., Significant diversification). A perfect positive correlation (i.e., a correlation coefficient of +1) implies that as Imunon moves, either up or down, the other security will move in the same direction. Alternatively, perfect negative correlation means that if Imunon Inc moves in either direction, the perfectly negatively correlated security will move in the opposite direction.

Imunon Correlation With Market

Average diversification

The correlation between Imunon Inc and DJI is 0.19 (i.e., Average diversification) for selected investment horizon. Overlapping area represents the amount of risk that can be diversified away by holding Imunon Inc and DJI in the same portfolio, assuming nothing else is changed.
  
Check out Risk vs Return Analysis to better understand how to build diversified portfolios, which includes a position in Imunon Inc. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in board of governors.

Moving together with Imunon Stock

  0.72FDMT 4D Molecular TherapeuticsPairCorr
  0.86JNJ Johnson Johnson Fiscal Year End 28th of January 2025 PairCorr
  0.9MRK Merck Company Fiscal Year End 6th of February 2025 PairCorr
  0.76MREO Mereo BioPharma GroupPairCorr
  0.86NKTX Nkarta Inc Buyout TrendPairCorr
  0.64PDSB PDS Biotechnology CorpPairCorr
  0.92PEPG PepGenPairCorr
  0.86ADAP Adaptimmune TherapeuticsPairCorr
  0.65ANEB Anebulo PharmaceuticalsPairCorr
  0.78BDTX Black Diamond TherapPairCorr
  0.85COLL Collegium PharmaceuticalPairCorr

Moving against Imunon Stock

  0.87BMY Bristol Myers Squibb Aggressive PushPairCorr
  0.85NAMS NewAmsterdam PharmaPairCorr
  0.54PMVP Pmv PharmaceuticalsPairCorr
  0.4PHVS Pharvaris BVPairCorr
  0.35ESLAW Estrella ImmunopharmaPairCorr
  0.84AVTE Aerovate TherapeuticsPairCorr
  0.8SGMO Sangamo Therapeutics Buyout TrendPairCorr
  0.79CRVS Corvus PharmaceuticalsPairCorr
  0.79VREX Varex Imaging CorpPairCorr
  0.75AGIO Agios PharmPairCorr

Related Correlations Analysis

Click cells to compare fundamentals   Check Volatility   Backtest Portfolio

Correlation Matchups

Over a given time period, the two securities move together when the Correlation Coefficient is positive. Conversely, the two assets move in opposite directions when the Correlation Coefficient is negative. Determining your positions' relationship to each other is valuable for analyzing and projecting your portfolio's future expected return and risk.
High positive correlations   
SNTINLTX
SABSWSABS
SNTICYCC
DMACXCUR
HSTOCYCC
HILSSNTI
  
High negative correlations   
HSTOXCUR
SABSWCYCC
NLTXXCUR
HILSDMAC
SABSCYCC
SABSWSNTI

Risk-Adjusted Indicators

There is a big difference between Imunon Stock performing well and Imunon Company doing well as a business compared to the competition. There are so many exceptions to the norm that investors cannot definitively determine what's good or bad unless they analyze Imunon's multiple risk-adjusted performance indicators across the competitive landscape. These indicators are quantitative in nature and help investors forecast volatility and risk-adjusted expected returns across various positions.
Mean DeviationJensen AlphaSortino RatioTreynor RatioSemi DeviationExpected ShortfallPotential UpsideValue @RiskMaximum Drawdown
XCUR  13.67  5.35  0.70  1.53  6.45 
 47.72 
 95.22 
CYCC  5.12 (1.64) 0.00 (3.11) 0.00 
 11.63 
 48.10 
HSTO  4.52 (1.29) 0.00  1.17  0.00 
 4.76 
 131.40 
DMAC  2.47  0.37  0.11  7.94  2.08 
 5.20 
 14.14 
NLTX  2.25 (0.12) 0.00  0.38  0.00 
 4.05 
 27.84 
SNTI  3.18 (0.33) 0.00 (1.95) 0.00 
 7.04 
 29.17 
HILS  5.56 (0.78) 0.00 (0.34) 0.00 
 8.33 
 113.15 
SABS  5.70  0.33  0.04  0.91  6.43 
 17.06 
 45.73 
QNRX  6.20  0.56  0.05 (0.76) 6.79 
 17.65 
 74.46 
SABSW  13.46  4.35  0.24 (7.97) 11.04 
 52.09 
 102.82 

Imunon Corporate Management

CPA CPAExec CFOProfile
Nicholas MDEx OfficerProfile
Susan EylwardGeneral SecretaryProfile
David GaieroChief OfficerProfile
Sebastien MDExecutive OfficerProfile